###begin article-title 0
###xml 67 102 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The integrase interactor 1 (INI1) proteins facilitate Tat-mediated human immunodeficiency virus type 1 transcription
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 15 50 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 212 217 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 381 386 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 606 609 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 711 716 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 749 754 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Integration of human immunodeficiency virus type 1 (HIV-1) into the host genome is catalyzed by the viral integrase (IN) and preferentially occurs within transcriptionally active genes. During the early phase of HIV-1 infection, the incoming viral preintegration complex (PIC) recruits the integrase interactor 1 (INI1)/hSNF5, a chromatin remodeling factor which directly binds to HIV-1 IN. The impact of this event on viral replication is so far unknown, although it has been hypothesized that it could tether the preintegration complex to transcriptionally active genes, thus contributing to the bias of HIV integration for these regions of the genome. Here, we demonstrate that while INI1 is dispensable for HIV-1 transduction, it can facilitate HIV-1 transcription by enhancing Tat function. INI1 bound to Tat and both the repeat (Rpt) 1 and Rpt 2 domains of INI1 were required for efficient activation of Tat-mediated transcription. These results suggest that the incoming PICs might recruit INI1 to facilitate proviral transcription.
###end p 2
###begin title 3
Finding
###end title 3
###begin p 4
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 291 292 291 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 356 365 356 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 366 367 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 519 520 519 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 581 586 581 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ini1 </italic>
###xml 680 681 680 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 849 850 849 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 851 852 851 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 106 141 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 143 148 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 319 324 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Integrase (IN) catalyses the integration of viral DNA into the host genome, which is an essential step of human immunodeficiency virus type 1 (HIV-1) replication [1]. Integrase interactor 1 (INI1), also known as hSNF5, a core component of ATP-dependent chromatin remodeling SWI/SNF complex [2], directly interacts with HIV-1 IN and stimulates its activity in vitro [3]. INI1 contains three conserved regions including two direct imperfect repeats, repeat Rpt 1 and Rpt2, and a carboxyl (C)-terminal coiled-coil domain [4]. INI1 also acts as a tumor suppressor, as mutations in the ini1 gene leads to aggressive pediatric atypical teratoid and malignant rhabdoid tumors (AT/MRTs) [5], suggesting a role for the SWI/SNF complex in control of the cell cycle. In fact, INI1 induces cell cycle arrest at G1 through repression of cyclin D1 transcription [6,7].
###end p 4
###begin p 5
###xml 122 123 122 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 450 452 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 453 455 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 694 696 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 76 94 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 129 149 <span type="species:ncbi:10566">human papillomavirus</span>
###xml 297 302 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 328 333 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 599 604 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 607 628 <span type="species:ncbi:10359">human cytomegalovirus</span>
###xml 630 633 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 668 686 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 725 730 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 925 930 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1018 1021 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1213 1218 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
INI1 has been reported to interact with other viral proteins, including the Epstein-Barr virus nuclear antigen 2 (EBNA2) [8-10], human papillomavirus E1 [11], and herpesvirus K8 [12] as well as cellular factors c-MYC [13], ALL1 (MLL) [14], GADD34 [15], and p53 [16]. During the early phase of the HIV-1 life cycle, the incoming HIV-1 preintegration complex (PIC) triggers the exportin-mediated cytoplasmic export of and associates with INI1 and PML [17,18]. The PML-nuclear body (PML-NB)/nuclear domain 10 (ND10)/PML oncogenic domain (POD) is a target of DNA viruses such as herpes simplex virus-1 (HSV-1), human cytomegalovirus (CMV), adenovirus, papillomavirus, and Epstein-Barr virus (EBV) [19]. The recruitment of PML to HIV-1 PICs could promote its association with PML-interacting proteins such as the histone acetyltransferase (HAT) CBP/p300, or with other transcription factors. Similarly, the binding of INI1 to the HIV-1 PICs may trigger the recruitment of the SWI/SNF complex to the PIC, possibly targeting HIV integration to actively transcribed regions of the genome or facilitating subsequent expression of the provirus. To probe these issues, we investigated the potential roles of INI1 and PML in HIV-1 integration and transcription.
###end p 5
###begin p 6
###xml 161 163 161 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 201 203 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 632 634 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 790 792 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1108 1110 1105 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1111 1113 1108 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1184 1189 1181 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ini1 </italic>
###xml 1273 1275 1270 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 1630 1632 1623 1625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 2082 2084 2075 2077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1c</xref>
###xml 33 38 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 867 872 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1011 1037 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
###xml 1039 1042 <span type="species:ncbi:11276">VSV</span>
###xml 1058 1062 <span type="species:ncbi:11676?0.7906976744186046">HIV1</span>
###xml 1330 1333 <span type="species:ncbi:11276">VSV</span>
###xml 1349 1354 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1647 1650 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1811 1816 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1856 1861 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1932 1937 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To analyze the effect of INI1 on HIV-1 transduction efficiency, we first used lentiviral vector-mediated RNA interference to stably knockdown INI1 protein in CD4+ LTR-beta-Gal HeLa-derived P4.2 cells [20]. Oligonucleotides with the following sense and antisense sequences were used for the cloning of small hairpin RNA (shRNA)-encoding sequences in lentiviral vector: INI1, 5'-GATCCCCAGGCAACAGGTCATGTTCATTCAAGAGATGAACATGACCTGTTGCCTTTTTTGGAAA-3' (sense), 5'-AGCTTTTCCAAAAAAGGCAACAGGTCATGTTCATCTCTTGAATGAACATGACCTGTTGCCTGGG-3' (antisense). The oligonucleotides above were annealed and subcloned into the BglII-HindIII site of pSUPER [21]. To construct pLVshRNA against INI1 (pLV281), the BamHI-SalI fragment of pSUPER-INI1i (pSP281) plasmid was subcloned into the BamHI-SalI site of pRDI292 [22], downstream from an RNA polymerase III promoter within the context of an HIV-1-derived self-inactivating lentiviral vector containing a puromycin marker allowing for the selection of the transduced cells. We used the vesicular stomatitis virus (VSV)-G pseudotyped HIV1 based vector system as previously described [23,24]. RT-PCR measurements demonstrated a very effective downregulation of ini1 mRNA in cells transduced with the lentiviral vector expressing the INI1 shRNA (Fig. 1a). These and control P4.2 cells were then exposed to a VSV-G-pseudotyped, HIV-1-derived lentiviral vector expressing GFP under the control of the E1Falpha promoter. FACS analyses performed forty-eight hours later revealed that the INI1 knockdown (INI1i) and control P4.2 cells (C) were equally susceptible to lentiviral vector-mediated transduction (Fig. 1b). As well, an HIV vector could effectively transduce INI1-deficient MON cells derived from a malignant rhabdoid tumor (data not shown), suggesting that INI1 is not essential for HIV-1 integration. We then measured rates of HIV-1 replication in the INI1 knockdown P4.2 cells. After infection with an HIV-1 X4 strain, p24 viral capsid levels were significantly reduced in the supernatant of INI1 knockdown cells compared with control P4.2 cells (Fig. 1c). In view of the normal transduction susceptibility of these cells, this results suggested a role for INI1 in later step of replication.
###end p 6
###begin p 7
###xml 0 42 0 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink">INI1 is dispensable for HIV-1 transduction</bold>
###xml 44 45 44 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 730 731 730 731 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1159 1160 1159 1160 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 24 29 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 918 921 <span type="species:ncbi:11276">VSV</span>
###xml 951 956 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1170 1175 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1258 1263 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1281 1286 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
INI1 is dispensable for HIV-1 transduction. a. Inhibition of ini1 expression by shRNA-producing lentiviral vector. Ethidium bromide-stained agarose gel analysis of RT-PCR amplification products of cytoplasmic RNA from INI1 knockdown P4.2 cells (INI1i) as well as in P4.2 cells transduced with a control (C) lentiviral vector. Cytoplasmic RNA was obtained using RNeasy kit (Qiagen) and RT-PCR was performed using SuperScript one-step RT-PCR with Platinum Taq kit (Invitrogen) with following primers: ini1, 5'-TCTGGAGGCGACTAGCCACTGTG-3' (forward primer) and 5'-GATCACAGCTGGGTCATGGTCATC-3' (reverse primer); beta-actin, 5'-TGACGGGGTCACCCACACTGTGCCCATCTA-3' (forward primer) and 5'-CTAGAAGCATTTGCGGTGGACGATGGAGGC-3' (reverse primer). b. Transduction efficiency in the same cells was determined by GFP fluorescence-activated cell sorter (FACS) analysis with a FACStrak apparatus (Becton Dickinson) 2 days after exposure to VSV-G-pseudotyped GFP-expressing HIV-1-derived lentiviral vector at the indicated MOI. Experiments were done in duplicate and columns represent the mean percentage of transduced cells, with mean fluorescence intensity (MFI) indicated below. c. Reduced HIV-1 replication in INI1 knockdown cells. INI1 knockdown P4.2 cells were infected with HIV-1 at a MOI of 0.5. HIV-1 replication was assayed by p24 ELISA in the culture supernatant 6 days later.
###end p 7
###begin p 8
###xml 73 75 73 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 276 281 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a</xref>
###xml 592 594 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b</xref>
###xml 724 726 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 796 798 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2c</xref>
###xml 1080 1082 1077 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2d</xref>
###xml 1212 1214 1209 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2e</xref>
###xml 49 54 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 183 188 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 300 305 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 488 492 <span type="species:ncbi:11676?0.7906976744186046">HIV1</span>
###xml 1298 1303 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To test the possibility that INI1 might modulate HIV-1 transcription, CD4+ HeLa P4.2 cells were cotransfected with plasmids expressing Tat and/or INI1, together with a Tat-responsive HIV-1-LTR-driven luciferase reporter plasmid [25]. INI1 significantly increased Tat-mediated trans-activation of the HIV-1 LTR (about 4 fold), while it had a negligible effect in the absence of transactivator (Fig. 2a). As well, INI1 could coactivate the Tat-mediated transcription of a stably integrated HIV1-LTR-beta-gal construct, as assessed by measuring LacZ activity in the transfected P4.2 cells (Fig. 2b). To identify the domain of Tat essential for response to INI1, we used the C-terminal deletion mutants of Tat, Tat72 and Tat86 [26]. INI1 could fully coactivate their transcriptional activities (Fig. 2c), indicating that the C-terminal domain of Tat (amino acids 73-101) is dispensable for transcriptional activation by INI1. Next, we found that Tat-mediated transcription was significantly inhibited in INI1 knockdown P4.2 cells compared to control, INI1-expressing P4.2 cells (Fig. 2d). Reciprocally, Tat activity was markedly increased in INI1 deficient MON cells when INI1 was reintroduced by transfection (Fig. 2e). Taken together, these data demonstrate that INI1 synergizes with Tat to activate HIV-1 transcription.
###end p 8
###begin p 9
###xml 0 49 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink">INI1 coactivates Tat-mediated HIV-1 transcription</bold>
###xml 51 52 51 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 72 74 72 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 510 511 510 511 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 673 674 673 674 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 858 859 858 859 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1092 1093 1092 1093 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 1127 1129 1127 1129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 30 35 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
INI1 coactivates Tat-mediated HIV-1 transcription. a. P4.2 cells (2 x 104 cells per well) were cotransfected with 100 ng of pHIV-1-LTR-Luc [25], 100 ng of pcDNA3-Tat101-FLAG [41], and/or 200 ng of pCGN-INI1 [7]. Luciferase assay was performed 24 h later. All transfections utilized equal total amounts of plasmid DNA owing to the addition of empty vector into the transfection mixture. Results were obtained through three independent transfections. Relative stimulation of luciferase activity (fold) is shown. b. 100 ng of pcDNA3-Tat101-FLAG, and/or 200 ng of pCGN-INI1 were cotransfected into P4.2 cells in triplicate. Beta-galactosidase activity was measured 24 h later. c. P4.2 cells were cotransfected with 100 ng of pHIV-1-LTR-Luc, 50 ng of pH2F Tat (Tat86) or pH2Tat (Tat72) [26], and/or 200 ng of pCGN-INI1 and performed luciferase assays 24 h later. d. 100 ng of pHIV-1-LTR-Luc, and/or 100 ng of pcDNA3-Tat101-FLAG were cotransfected into INI1 knockdown P4.2 cells (INI1i) or P4.2 cells transduced with a control (C) lentiviral vector and luciferase assays were performed 24 h later. e. INI1 deficient MON cells (2 x 104 cells per well) were cotransfected with 100 ng of pHIV-1-LTR-Luc, 50 ng of pcDNA3-Tat101-FLAG, and/or 200 ng of pCGN-INI1 and luciferase assays performed 24 h later.
###end p 9
###begin p 10
###xml 167 168 167 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
To probe the mechanism of this phenomenon, we performed co-immunoprecipitation analyses on extracts of 293T cells expressing FLAG-tagged Tat- and HA-tagged INI1 (Fig. 3). Both proteins could be immunoprecipitated with either anti-Flag or anti-HA antibody, indicating that they formed a complex, whether directly or indirectly.
###end p 10
###begin p 11
###xml 0 17 0 17 <bold xmlns:xlink="http://www.w3.org/1999/xlink">INI1 binds to Tat</bold>
###xml 240 241 238 239 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 243 244 241 242 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
INI1 binds to Tat. 293T cells were cotransfected with 5 mug of pcDNA3-Tat101-FLAG [41] and/or 5 mug of pCGN-HA-INI1 [7]. Cells were lysed in buffer containing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 4 mM EDTA, 0.1% NP-40, 10 mM NaF, 0.1 mM Na3VO4, 1 mM DTT and 1 mM PMSF. Lysates were pre-cleared with 30 mul of protein-G-sepharose (Amersham Biosciences). Pre-cleared supernatants were incubated with either 2 mug of anti-HA antibody (HA 11, Babco) or anti-FLAG antibody (M2, Sigma) at 4degreesC for 1 h. Following absorption of the precipitates on 30 mul of protein-G-sepharose resin for 1 h, the resin was washed four times with 700 mul lysis buffer. Bound proteins were eluted by boiling the resin for 5 min in 1x Laemmli sample buffer. The proteins were then subjected to SDS-PAGE, followed by immunoblotting analysis using either anti-HA or anti-FLAG antibodies.
###end p 11
###begin p 12
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a</xref>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b</xref>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4c</xref>
###xml 161 166 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 346 351 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 653 658 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To identify the domain of INI1 important for boosting Tat function, we co-expressed Tat and various INI1 deletion mutants [7] in 293T cells transfected with the HIV-1-LTR-luciferase plasmid (Fig. 4a). The full-length protein (INI1) and the two deletion mutants (20.2 and 1.2) still containing repeat Rpt 1 and Rpt2 domains increased Tat-mediated HIV-1 transcription by a factor ten (Fig. 4b). In contrast, mutants 3B and 27B, which lack the Rpt2 domain, could still bind Tat (Fig. 4c), but enhanced transcription by only 2-fold. These results suggest that both Rpt1 and Rpt2 domains of INI1 participate in allowing for full coactivation of Tat-mediated HIV-1 transcription. Interestingly, both Rpt1 and Rpt2 domain are required for the formation of a functional SWI/SNF complex.
###end p 12
###begin p 13
###xml 0 112 0 112 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Both Rpt1 and Rpt2 domains of INI1 are required for the efficient activation of Tat-mediated HIV-1 transcription</bold>
###xml 114 115 114 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 189 190 189 190 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 210 212 210 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 446 447 446 447 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 93 98 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Both Rpt1 and Rpt2 domains of INI1 are required for the efficient activation of Tat-mediated HIV-1 transcription. a. Schematic representation of HA-tagged full-length INI1 and its mutants. b. 293T cells (2 x 104 cells per well) were cotransfected with 100 ng of pHIV-1-LTR-Luc [25], 50 ng of pcDNA3-Tat101-FLAG [41], and/or 200 ng of pCGN-INI1 or its mutant (20.2, 1.2, 3B, 27B) [7] in triplicate and luciferase assays were performed 24 h later. c. 293T cells were cotransfected with 5 mug of pcDNA3-Tat101-FLAG and/or 5 mug of pCGN-HA-INI1 or its mutant (20.2, 3B, 27B) and IP-western blotting was performed in the similar way as shown in Fig. 3. Asterisk denotes HA-INI1 or its mutant.
###end p 13
###begin p 14
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 834 836 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1270 1272 1270 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1273 1275 1273 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 46 51 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 787 792 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1094 1099 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1179 1182 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Tat-mediated transactivation is essential for HIV-1 replication. Tat exerts its transcriptional effect by binding of P-TEFb, a transcription elongation factor composed of cyclin T1 and CDK9, and the interaction of Tat with P-TEFb and TAR leads to hyperphosphorylation of the C-terminal domain (CTD) of RNA polymerase II (Pol II) thus increasing the processivity of RNA Pol II [27]. In addition, it has been suggested that Tat plays a critical role in the assembly of the transcription complex (TC) during preinitiation [27]. It is likely that the interaction of Tat with the SWI/SNF chromatin remodeling complex promotes this step rather than the elongation of viral transcripts. Correspondingly, our data are consistent with recent reports indicating that SWI/SNF is recruited onto the HIV-1-LTR promoter in Tat-dependent manner [28-30]. These other studies further revealed that, in addition to INI1, Tat also recruits Brm or the closely related Brg-1, the ATPase subunit of the SWI/SNF complex. INI1 and Brg-1 then appear to synergize with the p300 histone acetyltransferase to activate the HIV-1 promoter. Both the binding of Tat to Brm and the synergistic activation of the HIV LTR by Tat and the SWI/SNF complex were found to require Tat acetylation on lysine 50 [28-30].
###end p 14
###begin p 15
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 503 505 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 532 537 532 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 805 807 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 30 35 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 383 386 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 423 427 <span type="species:ncbi:11676?0.7906976744186046">HIV1</span>
###xml 699 703 <span type="species:ncbi:11676?0.7906976744186046">HIV1</span>
###xml 1005 1010 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1177 1180 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
During the early phase of the HIV-1 life cycle, not only INI1 but also PML is exported to the cytoplasm where it can be found in association with the incoming preintegration complex [17,18]. The recruitment of PML to PICs could subsequently promote the association of PML-interacting proteins such as histone acetyltransferase (HAT) CBP/p300 or other transcription regulators to the HIV promoter. P300 was shown to bind to HIV1 IN and enhances the catalytic activity of this recombinase by acetylation [31]. Interestingly, Marcello et al. found that cyclin T1, the cellular cofactor of Tat responsible for phosphorylating the C-terminus of Pol II polymerase, hence of augmenting the processivity of HIV1 transcription, is recruited to PML nuclear bodies through a direct interaction with the PML protein [32]. Therefore, PML might regulate Tat-mediated transcription through its association with cyclin T1. However, we failed to observe significant effects of PML on Tat-mediated transcription as well as HIV-1 transduction efficiency in HeLa P4.2 cells in which levels of PML were decreased by at least 90% by RNA interference (data not shown). A possible influence of PML on HIV replication thus remains to be demonstrated, perhaps using other cellular systems and more effective knockdowns of this gene.
###end p 15
###begin p 16
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 390 391 390 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 517 519 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 572 581 572 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 582 584 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 655 657 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 772 774 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 834 836 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 970 971 970 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 987 989 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1000 1005 1000 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 1083 1085 1083 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 92 95 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 370 375 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 538 543 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 633 638 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 724 728 <span type="species:ncbi:11676?0.7906976744186046">HIV1</span>
###xml 759 764 <span type="species:ncbi:9606">human</span>
###xml 806 811 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 938 943 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1066 1071 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Retroviral integration favors active genes, MLV concentrating in and around promoters while HIV tends to land in the transcribed region of genes [33-35]. The determinant of such selectivity is unknown. High mobility group protein A1 (HMG-A1), barrier-to-autointegration factor (BAF) and Ku have been suggested to influence this step, as these proteins are found in both HIV-1 and MLV PICs [1]. Another candidate is lens epithelium-derived growth factor (LEDGF)/p75, which was identified as an IN-interacting protein [36] that can enhance HIV-1 IN strand transfer activity in vitro [36] and influence the intracellular trafficking of HIV-1 but not MLV IN [37]. Accordingly, it was recently demonstrated that LEDGF can affect HIV1 integration site selection in human cells [38]. Whether INI1, which binds to HIV-1 IN but not to MLV IN [39], also participates in this process remains to be established. While this protein is dispensable for HIV-1 transduction per se (Fig. 1 and reference [18]), Maroun et al. recently reported that INI1 interferes with early steps of HIV-1 infection [40]. Moreover, we did not ask whether integration site selection was modified in INI1 knockdown cells. While further studies are required to clarify the roles of factors that associate with the retroviral preintegration complex, the present work suggests that some of them may exert their effect after the provirus is established.
###end p 16
###begin title 17
Competing interests
###end title 17
###begin p 18
The author(s) declare that they have no competing interests.
###end p 18
###begin title 19
Authors' contributions
###end title 19
###begin p 20
YA carried out luciferase assay, immunoprecipitation, and was involved in drafting the manuscript. FS and PT carried out luciferase assays, western blotting, and PML knockdown study. AT participated in the construction of lentiviral vector expressing INI1 shRNA. DT participated in the design of the study and in drafting the manuscript.
###end p 20
###begin title 21
Acknowledgements
###end title 21
###begin p 22
We thank Bastien Mangeat, Sandrine Vianin, and Elisabeth Buhlmann for discussion and help with the experiments, and Monsef Benkirane, Masakazu Hatanaka, Hiroyuki Sakai, Yoshihiro Kitamura, Richard Iggo, and Ganjam V. Kalpana for the gift of reagents. This work was supported by the Swiss National Science Foundation, the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grant-in-Aid for Young Scientists (B) (18790326), and the Naito Foundation.
###end p 22
###begin article-title 23
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 24 52 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Human cell proteins and human immunodeficiency virus DNA integration
###end article-title 23
###begin article-title 24
Purification and biochemical heterogeneity of the mammalian SWI-SNF complex
###end article-title 24
###begin article-title 25
###xml 27 32 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 65 70 <span type="species:ncbi:4932">yeast</span>
Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5
###end article-title 25
###begin article-title 26
Structure-function analysis of integrase interactor 1/hSNF5L1 reveals differential properties of two repeat motifs present in the highly conserved region
###end article-title 26
###begin article-title 27
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
###end article-title 27
###begin article-title 28
Chromatin remodeling factor encoded by ini1 induces G1 arrest and apoptosis in ini1-deficient cells
###end article-title 28
###begin article-title 29
Cell cycle arrest and repression of cyclin D transcription by INI1/hSNF5
###end article-title 29
###begin article-title 30
###xml 13 31 <span type="species:ncbi:10376">Epstein-Barr virus</span>
CKII site in Epstein-Barr virus nuclear protein 2 controls binding to hSNF5/Ini1 and is important for growth transformation
###end article-title 30
###begin article-title 31
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 73 78 <span type="species:ncbi:9606">human</span>
Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1
###end article-title 31
###begin article-title 32
###xml 31 36 <span type="species:ncbi:9606">human</span>
###xml 56 74 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Promoter-specific targeting of human SWI-SNF complex by Epstein-Barr virus nuclear protein 2
###end article-title 32
###begin article-title 33
###xml 63 83 <span type="species:ncbi:10566">human papillomavirus</span>
Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA
###end article-title 33
###begin article-title 34
Kaposi's sarcoma-associated herpesvirus K8 protein interacts with hSNF5
###end article-title 34
###begin article-title 35
c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function
###end article-title 35
###begin article-title 36
The C-terminal SET domains of ALL-1 and TRITHORAX interact with the INI1 and SNR1 proteins, components of the SWI/SNF complex
###end article-title 36
###begin article-title 37
Leukemic HRX fusion proteins inhibit GADD34-induced apoptosis and associate with the GADD34 and hSNF5/INI1 proteins
###end article-title 37
###begin article-title 38
SWI/SNF complex interacts tumor suppressor p53 and is necessary for the activation of p53-mediated transcription
###end article-title 38
###begin article-title 39
###xml 52 55 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication
###end article-title 39
###begin article-title 40
Ini1/hSNF5 is dispensable for retrovirus-induced cytoplasmic accumulation of PML and does not interfer with integration
###end article-title 40
###begin article-title 41
Nuclear domain 10, the site of DNA virus transcription and replication
###end article-title 41
###begin article-title 42
###xml 0 4 <span type="species:ncbi:11676?0.7906976744186046">HIV1</span>
HIV1 reverse transcription. A termination step at the center of the genome
###end article-title 42
###begin article-title 43
A system for stable expression of short interfering RNAs in mammalian cells
###end article-title 43
###begin article-title 44
Induction of an interferon response by RNAi vectors in mammalian cells
###end article-title 44
###begin article-title 45
In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
###end article-title 45
###begin article-title 46
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
###end article-title 46
###begin article-title 47
###xml 25 29 <span type="species:ncbi:11676?0.7906976744186046">HIV1</span>
Functional cross-talk of HIV1 Tat with p53 through its C-terminal domain
###end article-title 47
###begin article-title 48
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A region of basic amino-acid cluster in HIV-1 Tat protein is essential for trans-acting activity and nucleolar localization
###end article-title 48
###begin article-title 49
Tat gets the "green" light on transcription initiation
###end article-title 49
###begin article-title 50
###xml 86 89 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The SWI/SNF chromatin-remodeling complex is a cofactor for Tat transactivation of the HIV promoter
###end article-title 50
###begin article-title 51
###xml 87 92 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter
###end article-title 51
###begin article-title 52
###xml 50 55 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription
###end article-title 52
###begin article-title 53
###xml 15 20 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Acetylation of HIV-1 integrase by p300 regulates viral integration
###end article-title 53
###begin article-title 54
###xml 15 20 <span type="species:ncbi:9606">human</span>
Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein
###end article-title 54
###begin article-title 55
Picking the right spot
###end article-title 55
###begin article-title 56
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 25 30 <span type="species:ncbi:9606">human</span>
HIV-1 integration in the human genome favors active genes and local hotspots
###end article-title 56
###begin article-title 57
###xml 35 40 <span type="species:ncbi:9606">human</span>
Transcription start regions in the human genome are favored targets for MLV integration
###end article-title 57
###begin article-title 58
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 80 85 <span type="species:ncbi:9606">human</span>
HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells
###end article-title 58
###begin article-title 59
###xml 72 78 <span type="species:ncbi:10090">murine</span>
LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes
###end article-title 59
###begin article-title 60
###xml 34 37 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
A role for LEDGF/p75 in targeting HIV DNA integration
###end article-title 60
###begin article-title 61
Specificity of interaction of INI1/hSNF5 with retroviral integrases and its functional significance
###end article-title 61
###begin article-title 62
###xml 29 34 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Inhibition of early steps of HIV-1 replication by SNF5/Ini1
###end article-title 62
###begin article-title 63
###xml 76 80 <span type="species:ncbi:11676?0.7906976744186046">HIV1</span>
A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV1 promoter
###end article-title 63

